Skip to main content
. 2023 Apr 12;10(3):2019–2030. doi: 10.1002/ehf2.14368

Table 1.

Baseline characteristics comparison between the three phenogroups in the derivation study

Phenogroup 1 (n = 125) Phenogroup 2 (n = 200) Phenogroup 3 (n = 40) P value
Demographics on admission
Age (years) 78.9 ± 9.1 78.8 ± 9.7 63.5 ± 11.2 <0.0001
Male, n (%) 72 (57.6) 85 (42.5) 23 (57.5) 0.0164
Clinical characteristics on admission
BMI at admission (kg/m2) 23.40 ± 3.60 22.78 ± 3.94 27.46 ± 5.85 <0.0001
HR (b.p.m.) 86.06 ± 26.04 92.97 ± 31.62 103.50 ± 29.73 <0.0001
SBP (mmHg) 149.06 ± 31.08 147.29 ± 32.68 175.78 ± 40.26 <0.0001
DBP (mmHg) 79.20 ± 20.76 79.70 ± 19.98 108.62 ± 27.18 <0.0001
NYHA, n (%) <0.0001
II 12 (10) 25 (13) 3 (8)
III 69 (55) 90 (45) 11 (28)
IV 44 (35) 85 (43) 26 (65)
Medical history on admission
Hypertension, n (%) 116 (92.8) 145 (72.5) 32 (80.0) <0.0001
Diabetes mellitus, n (%) 68 (54.4) 74 (37.0) 16 (40.0) 0.0079
Hyperlipidaemia, n (%) 61 (48.8) 55 (27.5) 21 (52.5) <0.0001
History of myocardial infarction, n (%) 50 (40.0) 11 (5.5) 9 (22.5) <0.0001
Atrial fibrillation, n (%) 49 (39.2) 113 (56.5) 16 (40.0) 0.005
Anaemia at discharge, n (%) 53 (42.5) 45 (22.5) 1 (2.5) <0.0001
Echocardiographic data on admission
LVEF (%) 60.4 ± 10.5 60.3 ± 12.1 54.5 ± 14.5 0.0156
LVDd (mm) 48.8 ± 0.66 46.7 ± 0.53 49.1 ± 1.19 0.0273
LVDs (mm) 32.9 ± 0.65 31.1 ± 0.53 35.7 ± 1.17 0.0009
Left ventricular hypertrophy, n (%) 40 (32) 19 (9.5) 19 (47.5) <0.0001
IVST (mm) 11.6 ± 2.3 10.3 ± 1.76 13.2 ± 3.8 <0.0001
PWT (mm) 11.2 ± 1.9 10.2 ± 1.7 12.5 ± 2.7 <0.0001
LAD (mm) 45.4 ± 8.7 44.8 ± 8.8 43.0 ± 6.3 0.429

BMI, body mass index; DBP, diastolic blood pressure; HR, heart rate; IVST, interventricular septal thickness; LAD, left arterial diameter; LVDd, left ventricular end‐diastolic diameter; LVDs, left ventricular end‐systolic diameter; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association functional classification; PWT, posterior wall thickness; SBP, systolic blood pressure.